Dow Up0.12% Nasdaq Up1.35%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
366.13 Down 3.52(0.95%) Oct 20, 4:00PM EDT
|After Hours : 366.15 Up 0.02 (0.01%) Oct 20, 6:49PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:378.70
Median Target:386.00
High Target:436.00
Low Target:305.00
No. of Brokers:20

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jul 21, 2014ArgusInitiated Buy
Apr 16, 2014Canaccord GenuityInitiated Buy
Feb 13, 2014OppenheimerDowngradeOutperformPerform
Aug 22, 2013OppenheimerInitiated Outperform
May 17, 2013UBSInitiated Neutral
Feb 28, 2013BarclaysInitiated Overweight
Jan 10, 2012Robert W. BairdUpgradeNeutralOutperform
Apr 29, 2011RBC Capital MktsDowngradeOutperformSector Perform
Apr 27, 2011Boenning & ScattergoodInitiated Outperform
Apr 7, 2011MP AdvisorsUpgradeMarket PerformOutperform

More Upgrades & Downgrades for REGN

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0665
Buy0666
Hold0777
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.